These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 2756718)
1. The percutaneous fate of the rodenticide flocoumafen in the rat: role of non-biliary intestinal excretion. Huckle KR; Morrison BJ; Warburton PA Xenobiotica; 1989 Jan; 19(1):63-74. PubMed ID: 2756718 [TBL] [Abstract][Full Text] [Related]
2. Studies on the fate of flocoumafen in the Japanese quail (Coturnix coturnix japonica). Huckle KR; Warburton PA; Forbes S; Logan CJ Xenobiotica; 1989 Jan; 19(1):51-62. PubMed ID: 2756717 [TBL] [Abstract][Full Text] [Related]
3. Elimination and accumulation of the rodenticide flocoumafen in rats following repeated oral administration. Huckle KR; Hutson DH; Warburton PA Xenobiotica; 1988 Dec; 18(12):1465-79. PubMed ID: 3245237 [TBL] [Abstract][Full Text] [Related]
4. Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding. el Dareer SM; Kalin JR; Tillery KF; Hill DL J Toxicol Environ Health; 1987; 22(4):405-15. PubMed ID: 3694703 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound. Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556 [TBL] [Abstract][Full Text] [Related]
6. Disposition of 9-aminoacridine in rats dosed orally or intravenously and in monkeys dosed topically. el Dareer SM; Kalin JR; Tillery KF; Hill DL J Toxicol Environ Health; 1985; 15(6):789-99. PubMed ID: 4057283 [TBL] [Abstract][Full Text] [Related]
7. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
8. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats. Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927 [TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of [14C]-haloperidol in rats. Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663 [TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
11. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Kurebayashi H; Betsui H; Ohno Y Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the osteotropic diphosphonate 3-amino-1-hydroxypropane-1,1-diphosphonic acid in mammals. Wingen F; Schmähl D Arzneimittelforschung; 1987 Sep; 37(9):1037-42. PubMed ID: 3435598 [TBL] [Abstract][Full Text] [Related]
13. Disposition of [14C]methyl bromide in Fischer-344 rats after oral or intraperitoneal administration. Medinsky MA; Bond JA; Dutcher JS; Birnbaum LS Toxicology; 1984 Sep; 32(3):187-96. PubMed ID: 6433513 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of labetalol by animals and man. Martin LE; Hopkins R; Bland R Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey. Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729 [TBL] [Abstract][Full Text] [Related]
17. Disposition of 2-(2-quinolyl)-1,3-indandione (D. C. yellow #11) in rats dosed orally or intravenously. el Dareer SM; Kalin JR; Tillery KF; Hill DL J Toxicol Environ Health; 1988; 23(3):385-93. PubMed ID: 3351983 [TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats. Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624 [TBL] [Abstract][Full Text] [Related]
19. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat. Eigenberg DA; Bozigian HP; Carter DE; Sipes IG J Toxicol Environ Health; 1986; 17(4):445-56. PubMed ID: 3959124 [TBL] [Abstract][Full Text] [Related]
20. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats. Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]